Lazard Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$660M Buy
718,105
+48,183
+7% +$48.8M 1.09% 17
2025
Q4
$720M Sell
669,922
-414,026
-38% -$396M 1.22% 16
2025
Q3
$827M Buy
1,083,948
+66,050
+6% +$49.2M 1.11% 17
2025
Q2
$793M Buy
1,017,898
+238,005
+31% +$185M 1.09% 14
2025
Q1
$644M Buy
779,893
+101,842
+15% +$84.7M 0.99% 19
2024
Q4
$523M Buy
678,051
+523,237
+338% +$433M 0.77% 35
2024
Q3
$137M Sell
154,814
-86,345
-36% -$77.6M 0.18% 104
2024
Q2
$218M Sell
241,159
-42,945
-15% -$34.4M 0.27% 75
2024
Q1
$221M Sell
284,104
-33,362
-11% -$23.7M 0.27% 83
2023
Q4
$185M Sell
317,466
-8,500
-3% -$4.96M 0.23% 97
2023
Q3
$175M Sell
325,966
-10,389
-3% -$5.35M 0.24% 96
2023
Q2
$158M Sell
336,355
-37,846
-10% -$15.9M 0.19% 111
2023
Q1
$129M Buy
374,201
+9,153
+3% +$3.09M 0.17% 119
2022
Q4
$134M Sell
365,048
-6,778
-2% -$2.4M 0.18% 104
2022
Q3
$120M Sell
371,826
-26,534
-7% -$8.41M 0.18% 112
2022
Q2
$129M Sell
398,360
-43,182
-10% -$13M 0.17% 110
2022
Q1
$126M Sell
441,542
-73,351
-14% -$18.9M 0.15% 132
2021
Q4
$142M Sell
514,893
-78,976
-13% -$20M 0.15% 120
2021
Q3
$137M Sell
593,869
-478,168
-45% -$118M 0.15% 117
2021
Q2
$246M Buy
1,072,037
+251,693
+31% +$50.6M 0.28% 85
2021
Q1
$153M Buy
820,344
+85,344
+12% +$16.7M 0.19% 102
2020
Q4
$124M Sell
735,000
-7,773
-1% -$1.16M 0.16% 122
2020
Q3
$110M Buy
742,773
+167,471
+29% +$25.9M 0.15% 121
2020
Q2
$94.5M Buy
575,302
+17,978
+3% +$2.76M 0.15% 124
2020
Q1
$77.3M Buy
557,324
+1,421
+0.3% +$195K 0.14% 122
2019
Q4
$73.1M Sell
555,903
-272,720
-33% -$31.6M 0.1% 154
2019
Q3
$92.7M Sell
828,623
-81,478
-9% -$9.07M 0.15% 125
2019
Q2
$101M Sell
910,101
-77,022
-8% -$9.07M 0.16% 118
2019
Q1
$128M Buy
987,123
+67,609
+7% +$8.22M 0.21% 99
2018
Q4
$106M Buy
919,514
+155,988
+20% +$17.4M 0.2% 106
2018
Q3
$81.9M Buy
763,526
+119,822
+19% +$12M 0.13% 135
2018
Q2
$54.9M Sell
643,704
-166,712
-21% -$13.7M 0.1% 161
2018
Q1
$62.7M Sell
810,416
-17,010
-2% -$1.37M 0.11% 146
2017
Q4
$69.9M Buy
827,426
+6,026
+0.7% +$513K 0.12% 136
2017
Q3
$70.3M Sell
821,400
-338,364
-29% -$27.8M 0.13% 129
2017
Q2
$95.4M Sell
1,159,764
-27,019
-2% -$2.2M 0.18% 101
2017
Q1
$99.8M Sell
1,186,783
-75,909
-6% -$6.08M 0.19% 94
2016
Q4
$92.9M Sell
1,262,692
-1,969,746
-61% -$147M 0.19% 95
2016
Q3
$259M Sell
3,232,438
-628,473
-16% -$50.3M 0.52% 58
2016
Q2
$304M Sell
3,860,911
-145,428
-4% -$10.9M 0.64% 43
2016
Q1
$288M Sell
4,006,339
-621,739
-13% -$47M 0.63% 47
2015
Q4
$390M Sell
4,628,078
-1,076,174
-19% -$89.3M 0.89% 28
2015
Q3
$477M Sell
5,704,252
-1,001,357
-15% -$84.5M 1.14% 18
2015
Q2
$560M Buy
6,705,609
+822,330
+14% +$62.7M 1.17% 18
2015
Q1
$427M Buy
5,883,279
+236,066
+4% +$16.8M 0.92% 22
2014
Q4
$390M Sell
5,647,213
-258,083
-4% -$17.4M 0.83% 25
2014
Q3
$383M Sell
5,905,296
-529,662
-8% -$33.5M 0.82% 32
2014
Q2
$400M Sell
6,434,958
-10,854
-0.2% -$648K 0.84% 34
2014
Q1
$379M Buy
6,445,812
+6,135,971
+1,980% +$342M 0.85% 31
2013
Q4
$15.8M Buy
309,841
+43,723
+16% +$2.19M 0.04% 285
2013
Q3
$13.4M Buy
266,118
+201,472
+312% +$10.5M 0.03% 297
2013
Q2
$3.17M Buy
+64,646
New +$3.52M 0.01% 566

Other funds holding LLY

Lazard Asset Management's LLY Position: Q1 2026 in Review

Lazard Asset Management increased its Eli Lilly (LLY) stake by 7.2% in Q1 2026, buying an estimated $48.8M and bringing the position to 718,105 shares worth $660M. The position accounts for 1.09% of the portfolio, ranked #17.

Lazard Asset Management first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $827M in Q3 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Lazard Asset Management held 718,105 shares of Eli Lilly worth $660M as of Q1 2026.
  • Lazard Asset Management bought 48,183 Eli Lilly shares in Q1 2026, an estimated $48.8M.
  • Eli Lilly made up 1.09% of Lazard Asset Management's portfolio in Q1 2026, its #17 holding.
  • Lazard Asset Management first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
  • Lazard Asset Management's Eli Lilly position peaked at $827M in Q3 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Lazard Asset Management's 13F filing for Q1 2026, filed 15 May 2026.